Published by Josh White on 2nd December 2022
(Sharecast News) - Stem-cell-derived exosome technology specialist ReNeuron Group reported first-half revenue of £0.44m on Friday, up from £0.06m year-on-year, related to income from partner-funded development activities and royalty income.
URL: http://www.digitallook.com/dl/news/story/33151695/...